Evidence map›Paper›PMID 42142380›Full record

ReviewCurrent opinion in hematology2026

G protein-coupled receptor-mediated platelet thrombus formation.

Xuefei Zhao, Peisong Ma

Abstract readReview
In one paragraph

Review in Current opinion in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xuefei ZhaoCardeza Foundation of Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Peisong Ma

Funding

Mechanism for feedback regulation of G protein-coupled receptor signaling in plateletsR01HL144574 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI MA, PEISONG · 2019 to 2022
$1.6M
NHLBI NIH HHS R01 HL144574
6 · The paper itself

Abstract

purpose of reviewPlatelet G protein-coupled receptor (GPCR) signaling plays a central role in platelet activation and thrombus formation; however, much of our current understanding of GPCR regulation is derived from isolated platelets and single-receptor knockout mouse models, and it does not fully capture vascular bed-specific regulation in vivo . This review highlights recent advances in GPCR regulatory mechanisms, including GPCR kinases (GRKs) and biased signaling, and discusses the challenges posed by interspecies differences in modeling and interpreting human thrombin/PAR signaling. RECENT

findingsRecent work reveals distinct roles of platelets in arterial thrombosis versus venous thromboembolism, platelet heterogeneity within developing thrombi, and the emergence of procoagulant platelets as a functional link between coagulation and thromboinflammation. Together, these findings indicate that platelet GPCR signaling should be reconsidered in the context of vascular bed-specific cues, platelet-immune cell crosstalk, and the spatial organization of growing thrombi, highlighting its dynamic and context-dependent nature. SUMMARY: Spatiotemporal regulation of platelet GPCR signaling provides a conceptual framework to better understand context-dependent platelet function in hemostasis and thrombosis and may inform the development of more selective antithrombotic strategies, including approaches that target specific GPCR downstream effectors or signaling bias while preserving physiological hemostasis.

Indexed as

Blood PlateletsReceptors, G-Protein-CoupledThrombosisAnimalsHumansPlatelet ActivationSignal TransductionReceptors, G-Protein-Coupledbiased signalingG protein-coupled receptorG protein-coupled receptor kinasesthrombin receptorthrombosis

Identifiers

PMID42142380
PMCPMC13459837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.